Global Opioids Agonist Drugs Market Research Report 2023(Status and Outlook)
- Published Date: 2023-08-20
- Report ID: 146233
- Pages: 250
-
Format:
Report Overview
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
Prudent Markets latest report provides a deep insight into the global Opioids Agonist Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Opioids Agonist Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Opioids Agonist Drugs market in any manner.
Global Opioids Agonist Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Market Segmentation (by Type)
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Market Segmentation (by Application)
Pain Management
Cough Treatment
Diarrhea Treatment
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Opioids Agonist Drugs Market
Overview of the regional outlook of the Opioids Agonist Drugs Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Opioids Agonist Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Opioids Agonist Drugs
1.2 Key Market Segments
1.2.1 Opioids Agonist Drugs Segment by Type
1.2.2 Opioids Agonist Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Opioids Agonist Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Opioids Agonist Drugs Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Opioids Agonist Drugs Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Opioids Agonist Drugs Market Competitive Landscape
3.1 Global Opioids Agonist Drugs Sales by Manufacturers (2018-2023)
3.2 Global Opioids Agonist Drugs Revenue Market Share by Manufacturers (2018-2023)
3.3 Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Opioids Agonist Drugs Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Opioids Agonist Drugs Sales Sites, Area Served, Product Type
3.6 Opioids Agonist Drugs Market Competitive Situation and Trends
3.6.1 Opioids Agonist Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Opioids Agonist Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Opioids Agonist Drugs Industry Chain Analysis
4.1 Opioids Agonist Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Opioids Agonist Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Opioids Agonist Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Opioids Agonist Drugs Sales Market Share by Type (2018-2023)
6.3 Global Opioids Agonist Drugs Market Size Market Share by Type (2018-2023)
6.4 Global Opioids Agonist Drugs Price by Type (2018-2023)
7 Opioids Agonist Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Opioids Agonist Drugs Market Sales by Application (2018-2023)
7.3 Global Opioids Agonist Drugs Market Size (M USD) by Application (2018-2023)
7.4 Global Opioids Agonist Drugs Sales Growth Rate by Application (2018-2023)
8 Opioids Agonist Drugs Market Segmentation by Region
8.1 Global Opioids Agonist Drugs Sales by Region
8.1.1 Global Opioids Agonist Drugs Sales by Region
8.1.2 Global Opioids Agonist Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Opioids Agonist Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Opioids Agonist Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Opioids Agonist Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Opioids Agonist Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Opioids Agonist Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Purdue Pharma
9.1.1 Purdue Pharma Opioids Agonist Drugs Basic Information
9.1.2 Purdue Pharma Opioids Agonist Drugs Product Overview
9.1.3 Purdue Pharma Opioids Agonist Drugs Product Market Performance
9.1.4 Purdue Pharma Business Overview
9.1.5 Purdue Pharma Opioids Agonist Drugs SWOT Analysis
9.1.6 Purdue Pharma Recent Developments
9.2 Titan pharmaceuticals
9.2.1 Titan pharmaceuticals Opioids Agonist Drugs Basic Information
9.2.2 Titan pharmaceuticals Opioids Agonist Drugs Product Overview
9.2.3 Titan pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.2.4 Titan pharmaceuticals Business Overview
9.2.5 Titan pharmaceuticals Opioids Agonist Drugs SWOT Analysis
9.2.6 Titan pharmaceuticals Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Opioids Agonist Drugs Basic Information
9.3.2 Boehringer Ingelheim Opioids Agonist Drugs Product Overview
9.3.3 Boehringer Ingelheim Opioids Agonist Drugs Product Market Performance
9.3.4 Boehringer Ingelheim Business Overview
9.3.5 Boehringer Ingelheim Opioids Agonist Drugs SWOT Analysis
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Janssen Pharmaceuticals, Inc
9.4.1 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Basic Information
9.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Overview
9.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Market Performance
9.4.4 Janssen Pharmaceuticals, Inc Business Overview
9.4.5 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs SWOT Analysis
9.4.6 Janssen Pharmaceuticals, Inc Recent Developments
9.5 Sanofi
9.5.1 Sanofi Opioids Agonist Drugs Basic Information
9.5.2 Sanofi Opioids Agonist Drugs Product Overview
9.5.3 Sanofi Opioids Agonist Drugs Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Opioids Agonist Drugs SWOT Analysis
9.5.6 Sanofi Recent Developments
9.6 Sun Pharmaceuticals
9.6.1 Sun Pharmaceuticals Opioids Agonist Drugs Basic Information
9.6.2 Sun Pharmaceuticals Opioids Agonist Drugs Product Overview
9.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.6.4 Sun Pharmaceuticals Business Overview
9.6.5 Sun Pharmaceuticals Recent Developments
9.7 Mallinckrodt Pharmaceuticals
9.7.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Basic Information
9.7.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Overview
9.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Market Performance
9.7.4 Mallinckrodt Pharmaceuticals Business Overview
9.7.5 Mallinckrodt Pharmaceuticals Recent Developments
9.8 Egalet Corporation
9.8.1 Egalet Corporation Opioids Agonist Drugs Basic Information
9.8.2 Egalet Corporation Opioids Agonist Drugs Product Overview
9.8.3 Egalet Corporation Opioids Agonist Drugs Product Market Performance
9.8.4 Egalet Corporation Business Overview
9.8.5 Egalet Corporation Recent Developments
9.9 Endo Pharmaceuticals Inc.
9.9.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Basic Information
9.9.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Overview
9.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Market Performance
9.9.4 Endo Pharmaceuticals Inc. Business Overview
9.9.5 Endo Pharmaceuticals Inc. Recent Developments
9.10 Allergan, Plc
9.10.1 Allergan, Plc Opioids Agonist Drugs Basic Information
9.10.2 Allergan, Plc Opioids Agonist Drugs Product Overview
9.10.3 Allergan, Plc Opioids Agonist Drugs Product Market Performance
9.10.4 Allergan, Plc Business Overview
9.10.5 Allergan, Plc Recent Developments
9.11 Pfizer Inc
9.11.1 Pfizer Inc Opioids Agonist Drugs Basic Information
9.11.2 Pfizer Inc Opioids Agonist Drugs Product Overview
9.11.3 Pfizer Inc Opioids Agonist Drugs Product Market Performance
9.11.4 Pfizer Inc Business Overview
9.11.5 Pfizer Inc Recent Developments
10 Opioids Agonist Drugs Market Forecast by Region
10.1 Global Opioids Agonist Drugs Market Size Forecast
10.2 Global Opioids Agonist Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Opioids Agonist Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Opioids Agonist Drugs Market Size Forecast by Region
10.2.4 South America Opioids Agonist Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Opioids Agonist Drugs by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Opioids Agonist Drugs Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Opioids Agonist Drugs by Type (2024-2029)
11.1.2 Global Opioids Agonist Drugs Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Opioids Agonist Drugs by Type (2024-2029)
11.2 Global Opioids Agonist Drugs Market Forecast by Application (2024-2029)
11.2.1 Global Opioids Agonist Drugs Sales (K MT) Forecast by Application
11.2.2 Global Opioids Agonist Drugs Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
